—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Hinge Health, Inc.（HNGE）— 同業公司組

數據截至2026-10-14 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。

Hinge Health, Inc.的Closelook綜合評分為56/100，在同業公司組內排名第7位（共9家）——組內評分最高的是Halozyme Therapeutics Inc（74/100）。

名稱綜合動能品質估值訊號距52週高點
HNGE Hinge Health, Inc.56966323ok1.9%
HQY HealthEquity Inc61566942info16.5%
VEEV Veeva Systems Inc Class A60957427bull2.9%
BTSG BrightSpring Health Services, Inc. Common Stock49672536ok14.1%
TEM Tempus AI, Inc. Class A Common Stock39721813bull34.6%
HALO Halozyme Therapeutics Inc74979447ok2%
DXCM DexCom Inc65818034bull8.1%
ARGX argenx NV ADR61507427info23.7%
KRYS Krystal Biotech Inc61688516info13.6%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-14

Quick answers

Hinge Health, Inc.在Closelook涵蓋範圍內的同業公司有哪些？

分組首先根據共同的Closelook指數成分，其次根據產業：HealthEquity Inc (HQY)、Veeva Systems Inc Class A (VEEV)、BrightSpring Health Services, Inc. Common Stock (BTSG)、Tempus AI, Inc. Class A Common Stock (TEM)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)、argenx NV ADR (ARGX)、Krystal Biotech Inc (KRYS)。

HNGE相對同業公司的評分如何？

Hinge Health, Inc.的綜合評分為56/100，組內排名第7位（共9家），截至2026-10-14；組內最高綜合評分為Halozyme Therapeutics Inc（74/100）。Closelook評分為研究日記讀數，不構成評等或投資建議。

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.